Stockreport

Contineum Therapeutics, Inc. (NASDAQ:CTNM) surges 10%; retail investors who own 51% shares profited along with institutions [Yahoo! Finance]

Contineum Therapeutics, Inc. - Common stock  (CTNM) 
PDF 47% of the business is held by the top 25 shareholders 37% of Contineum Therapeutics is held by Institutions Trump has pledged to "unleash" American oil and gas and [Read more]